Opko Health (OPK) Capital Expenditures (2010 - 2026)

Opko Health has reported Capital Expenditures for 17 years, with the latest figure at $1.8 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 42.61% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at $10.9 million (down 71.93% YoY), and the FY2025 full-year result was $12.3 million, down 50.91% from the prior year.
• Capital Expenditures for Q1 2026 stood at $1.8 million, down from $2.7 million in the prior quarter.
• The five-year high for Capital Expenditures was $19.6 million in Q3 2024, with the low at $1.8 million in Q1 2026.
• Historically, Capital Expenditures has averaged $5.7 million across 5 years, with a median of $4.3 million in 2023.
• Annual changes were most pronounced in 2024 — Capital Expenditures surged 366.26% — and 2025, when it slumped 84.0%.
• Opko Health's Capital Expenditures stood at $6.3 million in 2022, then plunged by 52.3% to $3.0 million in 2023, then soared by 548.48% to $19.6 million in 2024, then plunged by 86.4% to $2.7 million in 2025, then slumped by 31.25% to $1.8 million in 2026.
• The last three Capital Expenditures figures came in at $1.8 million (Q1 2026), $2.7 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.